Antioxidant enzymes
SOD2 · GPX1 · CAT · NQO1
SOD2, GPX1, catalase and NQO1 take part in different cellular processes involving reactive molecules. Common variants in these genes have been studied in functional and association research. A marker profile does not measure a person's oxidative stress or antioxidant capacity.
Key points
- Some variants have been associated with differences in enzyme function in specific experiments.
- Effects of individual variants do not produce a reliable overall measure of cellular defence.
- This profile cannot establish a diagnosis or a supplement recommendation.
The four steps
rs4880 (SOD2, Ala16Val): mitochondrial manganese superoxide dismutase converts superoxide into H₂O₂. The variant sits in the mitochondrial targeting sequence; the Ala allele is imported efficiently and yields about 40 percent more active enzyme there, while the Val allele is partly arrested in the inner membrane and degraded (Sutton 2005). rs1050450 (GPX1, Pro198Leu): glutathione peroxidase 1 further breaks down H₂O₂; the Leu allele goes along with lower enzyme activity (Arsova-Sarafinovska 2008). rs1001179 (CAT, catalase): a direct H₂O₂ detoxifier; the effect allele lowers expression. rs1800566 (NQO1, Pro187Ser): protects against quinone toxicity; the T allele contributes substantially to population variation in enzyme activity, and homozygous carriers have very low residual activity (Lajin 2013).
What it means
The four markers do not measure enzyme activity or form a validated measure of oxidative stress. Environment, tissue, cell state and other genetic factors affect these processes. The profile cannot establish an individual's sensitivity to exposures or a benefit from antioxidant supplements.
Context
The functional effects of the individual variants are documented; their disease associations are inconsistent by population and should not be over-interpreted. Genome shows the markers as technical evidence.
What Genome measures. The genotypes at rs4880 (SOD2), rs1050450 (GPX1), rs1001179 (CAT) and rs1800566 (NQO1).
Related topics
Sources
- 1Sutton et al., 2005 The MnSOD Ala16Val dimorphism modulates mitochondrial import and mRNA stability. Pharmacogenetics and Genomics 15:311-319. doi.org/10.1097/01213011-200505000-00006
- 2Arsova-Sarafinovska et al., 2008 GPX1 genetic polymorphism, erythrocyte GPX activity and prostate cancer risk. International Urology and Nephrology 41:63-70. doi.org/10.1007/s11255-008-9407-y
- 3Lajin & Alachkar, 2013 The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a meta-analysis. British Journal of Cancer 109:1325-1337. doi.org/10.1038/bjc.2013.357